Cargando…
In Vitro activity of a Novel Benzoquinolizine Antibiotic, Levonadifloxacin (WCK 771) against Blood Stream Gram-Positive Isolates from a Tertiary Care Hospital
Background Blood stream infections (BSIs) due to Gram-positive pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) are associated with high mortality ranging from 10 to 60%. The current anti-MRSA agents have limitations with regards to safety and tolerability profile which limits t...
Autores principales: | Mamtora, Dhruv, Saseedharan, Sanjith, Rampal, Ritika, Joshi, Prashant, Bhalekar, Pallavi, Ahdal, Jaishid, Jain, Rishi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684988/ https://www.ncbi.nlm.nih.gov/pubmed/33268943 http://dx.doi.org/10.1055/s-0040-1720944 |
Ejemplares similares
-
Efficient Synthesis of Potential Impurities in Levonadifloxacin
(WCK 771)
por: Kilbile, Jaydeo T., et al.
Publicado: (2021) -
Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current Evidence
por: Bhagwat, Sachin S, et al.
Publicado: (2019) -
Microbiological profile and antibiotic susceptibility pattern of Gram-positive isolates at a tertiary care hospital
por: Mamtora, Dhruv, et al.
Publicado: (2019) -
Electrocardiographic Effects of a Supratherapeutic Dose of WCK 2349, a Benzoquinolizine Fluoroquinolone
por: Mason, Jay W., et al.
Publicado: (2018) -
Meeting the Unmet Need in the Management of MDR Gram-Positive Infections with Oral Bactericidal Agent Levonadifloxacin
por: Mehta, Yatin, et al.
Publicado: (2022)